Back to Browse Journals » Patient Preference and Adherence » Volume 6

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures

Authors Pesa JA, Van Den Bos J, Gray T, Hartsig C, McQueen RB, Saseen JJ, Nair KV

Published Date January 2012 Volume 2012:6 Pages 63—72

DOI http://dx.doi.org/10.2147/PPA.S28396

Received 20 November 2011, Accepted 13 December 2011, Published 18 January 2012

Jacqueline A Pesa1, Jill Van Den Bos2, Travis Gray2, Colleen Hartsig2, Robert Brett McQueen3, Joseph J Saseen3, Kavita V Nair3
1Janssen Scientific Affairs, LLC, Louisville, CO, USA; 2Milliman, Inc, Denver, CO, USA; 3University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Objective: To assess the impact of patient cost-sharing for antihypertensive medications on the proportion of days covered (PDC) by antihypertensive medications, medical utilization, and health care expenditures among commercially insured individuals assigned to different risk categories.
Methods: Participants were identified from the Consolidated Health Cost Guidelines (CHCG) database (January 1, 2006–December 31, 2008) based on a diagnosis (index) claim for hypertension, continuous enrollment ≥12 months pre- and post-index, and no prior claims for antihypertensive medications. Participants were assigned to: low-risk group (no comorbidities), high-risk group (1+ selected comorbidities), or very high-risk group (prior hospitalization for 1+ selected comorbidities). The relationship between patient cost sharing and PDC by antihypertensive medications was assessed using standard linear regression models, controlling for risk group membership, and various demographic and clinical factors. The relationship between PDC and health care service utilization was subsequently examined using negative binomial regression models.
Results: Of the 28,688 study patients, 66% were low risk. The multivariate regression model supported a relationship between patient cost sharing per 30-day fill and PDC in the following year. For every US$1.00 increase in cost sharing, PDC decreased by 1.1 days (P < 0.0001). Significant predictors of PDC included high risk, older age, gender, Charlson Comorbidity Index score, geography, and total post-index insurer- and patient-paid costs. An increase in PDC was associated with a decrease in all-cause and hypertension-related inpatient, outpatient, and emergency room visits and medical, pharmacy, and total costs.
Conclusions: The trend has been for managed care organizations and employers to require patients to bear a greater out-of-pocket burden for health care resources consumed. This study illustrates the potential adverse effects of higher patient cost sharing among patients with hypertension stratified by different risk levels. A decrease in PDC was predictive of higher resource utilization and health care costs, which should be of interest to payers and employers alike.

Keywords: hypertension, adherence, cost sharing, outcomes

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

Page RL 2nd, Ghushchyan V, Allen RR, Roper L, Beck D, Johnathan BH, Frech-Tamas F, Chan W, McQueen RB, Nair KV

Drug, Healthcare and Patient Safety 2012, 4:67-74

Published Date: 10 July 2012

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

Nair KV, Belletti D, Doyle J, Allen R, McQueen R, Saseen J, Griend J, Patel J, McQueen A, Jan S

Patient Preference and Adherence 2011, 5:195-206

Published Date: 29 April 2011

Readers of this article also read:

Let’s talk about medication: concordance in rating medication adherence among multimorbid patients and their general practitioners

Ose D, Mahler C, Vogel I, Ludt S, Szecsenyi J, Freund T

Patient Preference and Adherence 2012, 6:839-845

Published Date: 28 November 2012

The roles of past behavior and health beliefs in predicting medication adherence to a statin regimen

Molfenter TD, Bhattacharya A, Gustafson DH

Patient Preference and Adherence 2012, 6:643-651

Published Date: 6 September 2012

Beliefs that influence cost-related medication non-adherence among the “haves” and “have nots” with chronic diseases

Piette JD, Beard A, Rosland AM, McHorney CA

Patient Preference and Adherence 2011, 5:389-396

Published Date: 3 August 2011

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

Nair KV, Belletti D, Doyle J, Allen R, McQueen R, Saseen J, Griend J, Patel J, McQueen A, Jan S

Patient Preference and Adherence 2011, 5:195-206

Published Date: 29 April 2011

Compliance, concordance, and patient-centered care

Sharon Lawn

Patient Preference and Adherence 2011, 5:89-90

Published Date: 9 February 2011

Update on the diagnosis and management of acute kidney injury

Ali Akcay, Kultigin Turkmen, DongWon Lee, et al

International Journal of Nephrology and Renovascular Disease 2010, 3:129-140

Published Date: 29 September 2010

Biologic response of animals to husbandry stress with implications for biomedical models

Bernadette Earley, Kelly Buckham-Sporer, Sandeep Gupta, et al

Open Access Animal Physiology 2010, 2:25-42

Published Date: 4 August 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Bone resorption in incompletely impacted mandibular third molars and acute pericoronitis

Minoru Yamaoka, Yusuke Ono, Masahiro Takahashi, Ryosuke Doto, et al.

Clinical, Cosmetic and Investigational Dentistry 2009, 1:7-12

Published Date: 14 April 2009